Genesis Research and Grants Administration & Institutional Review Board (IRB)

 

Our Vision

National Sponsors and principal investigators will see Genesis as a "preferred site" for high quality clinical trials, allowing our patients to receive the most innovative treatments and technologies close to home.

Our Philosophy

Genesis Health System intends to provide research opportunities for the promotion of innovative and quality healthcare within our community. These include numerous clinical trials that explore new medications, treatments, and therapeutic devices that may help people dealing with a wide variety of diseases.

Our goal is to support and encourage clinicians as they seek to combine professional development and research activities with the demands of caring for their patients.

We also recognize that Genesis's diverse clinical settings make the system an especially attractive research site. We work with outside research sponsors to help them see the unique advantages of Genesis Health System facilities as research venues. We believe everyone benefits when we make it possible for professionals to develop new skills and stay abreast of emerging technologies.

At any one time, Genesis Health System has over 175 research studies open that patient's are participating in. For a list of studies open to enrollment, please refer to the Research tab below.

Genesis Research Inquirer Newsletter

May/Jun 2014 Issue

Mar/Apr 2014 Issue

Jan/Feb 2014 Issue

Please use the tabs to access information about the Research and Grants programs at Genesis and the IRB.

Requests for information regarding Significant Financial Interests held by researchers on federally funded studies can be obtained within 5 days of receipt by contacting the Research & Grants Administration office at:

Genesis Health System Office of Research & Grants Administration
1227 East Rusholme Street
Davenport, IA  52803
563-421-7955
research@genesishealth.com

Research

The physicians of the Quad Cities are committed to bringing cutting edge treatment to patients through their participation in clinical research. Genesis Health System, in its commitment to this research, has established the Research and Grants Administration (RGA) department. The RGA helps to facilitate the approval process for new studies, provides a resource for the research community and supports the health system's Institutional Review Board (IRB).

Clinical Trials Currently Open At Genesis

Research Promotion Fund Policy

clinicaltrials.gov

Conflict of Interest in Research Policy

Conflict of Interest Reporting (COI Smart)

Informed Consent Template/Guide

IRBNet

Research Promotion Fund Application

Grants

By developing a comprehensive organizational approach to grants management, Genesis has prepared itself to apply for and receive federal funding for it's many quality, patient care and research activities. Currently, the focus for Genesis is on Research, Patient Safety/Quality, Growth Opportunities and funding to create an Accountable Care Organization. 

Listed below are links to key funding agencies:

grants.gov

AHRQ

NIH

HRSA

IRB

The Institutional Review Board (IRB) of Genesis Health System (GHS) is formally designated to review, to approve the initiation of, and to conduct periodic review of any biomedical research projects being carried out in GHS which involve human subjects. The primary function of the IRB is to maximize the protection and welfare of the human subjects involved in any project. Any clinical investigation involving a reasonable expectation that a human subject of research will receive treatment at a GHS entity must first be reviewed and approved by and remain subject to continuing monitoring by the IRB.

IRB Standard Operating Procedures

Genesis IRB Guidance on the Informed Consent Process

2014 Genesis IRB Schedule

IRBNet User's Guide

Preparatory Research Request Form

Privacy Pathways 

Waiver HIPAA Authorization

Waiver of HIPAA Authorization Criteria

© 2014 Genesis Health System - All rights reserved.

1227 E. Rusholme Street Davenport, IA 52803 563-421-1000